Alterity Therapeutics Limited (ATHE) Ownership
ATHE ownership summary
as of October 18, 2026- Institutions
- 2.1% of shares outstanding
- Insiders
- 0.00% of shares outstanding
- Shares outstanding
- 18.2M
- Float
- 14.4M shares available to trade
- Short interest
- 0.14% 26K shares short
- Days to cover
- 1.68 short interest up 1.7% vs prior month
- Institutions 2.06%
- Other investors 97.94%
ATHE top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Twin Lakes Capital Management, LLC | 0.76% | 139K | $364,856 | — | June 30, 2026 |
| 2 | Morgan Stanley - Brokerage Accounts | 0.35% | 63K | $165,230 | +4,683 (+8.0%) | June 30, 2026 |
| 3 | Greenleaf Trust | 0.34% | 62K | $162,440 | +30,000 (+93.8%) | June 30, 2026 |
| 4 | HB Wealth Management, LLC | 0.32% | 58K | $153,165 | — | June 30, 2026 |
| 5 | Citadel Advisors Llc | 0.21% | 38K | $98,504 | +17,520 (+87.3%) | June 30, 2026 |
| 6 | HRT FINANCIAL LLC | 0.10% | 17K | $45,305 | +17,292 (0.0%) | June 30, 2026 |
| 7 | BNP Paribas Arbitrage, SA | 0.06% | 10K | $26,826 | +3,430 (+50.4%) | June 30, 2026 |
| 8 | GAMMA Investing LLC | 0.01% | 2,309 | $6,050 | +453 (+24.4%) | June 30, 2026 |
| 9 | Rhumbline Advisers | 0.01% | 2,009 | $5,264 | +39 (+2.0%) | June 30, 2026 |
| 10 | Acadian Asset Management LLC | 0.01% | 1,863 | $4,881 | — | June 30, 2026 |
| 11 | Providence Capital Advisors, LLC | <0.01% | 200 | $524 | +200 (0.0%) | June 30, 2026 |
| 12 | Integrated Wealth Concepts LLC | <0.01% | 73 | $191 | +73 (0.0%) | June 30, 2026 |
| 13 | Advisor Group Holdings, Inc. | <0.01% | 68 | $178 | — | June 30, 2026 |
| 14 | Ronald Blue Trust, Inc. | <0.01% | 40 | $105 | — | June 30, 2026 |
| 15 | CoreCap Advisors, LLC | <0.01% | 21 | $55 | — | June 30, 2026 |
| 16 | Steward Partners Investment Advisory, LLC | 0.00% | 6 | $16 | — | June 30, 2026 |
| 17 | UBS Group AG | 0.00% | 5 | $13 | +5 (0.0%) | June 30, 2026 |
| 18 | Caitong International Asset Management Co., Limited. | 0.00% | 1 | $3 | +1 (0.0%) | June 30, 2026 |
| 19 | Cranbrook Wealth Management, LLC | 0.00% | 1 | $3 | +1 (0.0%) | June 30, 2026 |
| 20 | Citigroup Inc | 0.00% | 1 | $3 | +1 (0.0%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 13 holders added 74K shares and 0 cut 0.
ATHE top mutual fund and ETF holders
1 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Fidelity Nasdaq Composite Index | 0.01% | 1,155 | $3,026 | — | May 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
ATHE shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns ATHE
Institutional investors own 2.1% of Alterity Therapeutics's shares and insiders 0.00%. The largest holder is Twin Lakes Capital Management, LLC with 0.76% of the shares (139K), as of June 30, 2026. Among the top 20 institutions, 13 added shares and 0 reduced their stake in the latest filings. Short interest is 0.14% of the float, or 1.68 days of average trading volume. The share count rose 1,982.2% since 2014.
Related: ATHE analyst forecast, ATHE key metrics. See the ATHE stock overview for the latest quote and news.
ATHE ownership FAQ
Who owns the most Alterity Therapeutics stock?
The largest shareholders of Alterity Therapeutics are Twin Lakes Capital Management, LLC (0.76%), Morgan Stanley - Brokerage Accounts (0.35%), Greenleaf Trust (0.34%), HB Wealth Management, LLC (0.32%), Citadel Advisors Llc (0.21%).
What percentage of Alterity Therapeutics is owned by institutions?
Institutions hold 2.1% of Alterity Therapeutics's shares outstanding; insiders hold 0.00%.
Which funds own Alterity Therapeutics?
The largest fund holders of Alterity Therapeutics are Fidelity Nasdaq Composite Index (0.01%).
What is Alterity Therapeutics's short interest?
26K shares of Alterity Therapeutics were sold short, 0.14% of the float; at the average daily volume it would take 1.68 days to cover.
How many shares of Alterity Therapeutics are outstanding?
Alterity Therapeutics has 18.2M shares outstanding, of which 14.4M are in the public float.